2016;19(2):651 -9. Abbreviated Title: Ad5 -based combination vaccines Version Date: 05.16.2018 70 30. Palena C, Polev DE, Tsang KY, Fern ando RI, Litzinger M, Krukovskaya LL, et al. The human T -box mesodermal transcription factor Brachyury is a candidate target for T -cell- mediated cancer immunotherapy. Clin Cancer Res.